R&G PharmaStudies Co., Ltd. (SHE:301333)

China · Delayed Price · Currency is CNY

66.28

+0.49 (0.74%)

At close: Mar 5, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2015	FY 2014	FY 2013
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Medical Labs & Research	744.00M	721.37M	637.52M	608.43M	484.45M
Medical Labs & Research Growth	3.14%	13.15%	4.78%	25.59%	13.87%
Total	744.00M	721.37M	637.52M	608.43M	484.45M
Total Growth	3.14%	13.15%	4.78%	25.59%	13.87%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2015	FY 2014	FY 2013
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
China	664.58M	674.39M	605.02M	576.29M	-
China Growth	-1.45%	11.47%	4.98%	-	-
Overseas	79.42M	46.98M	32.50M	32.13M	-
Overseas Growth	69.04%	44.57%	1.14%	-	-
Total	744.00M	721.37M	637.52M	608.43M	-
Total Growth	3.14%	13.15%	4.78%	-	-

Source: S&P Global Market Intelligence.